查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年光動態治療 (PDT) 市場預測：按細分市場和地區分類的全球分析
市場調查報告書
商品編碼
1358961

2030 年光動態治療 (PDT) 市場預測：按細分市場和地區分類的全球分析

Photodynamic Therapy Market Forecasts to 2030 - Global Analysis By Product (Photosensitizer Drugs, Photodynamic Therapy Devices and Other Products), Indication, Treatment Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球動態治療 (PDT) 市場規模為 56 億美元，預計在預測期內將以 15.5% 的年複合成長率成長，到 2030 年達到 153.6 億美元。

動態療法 (PDT) 使用光敏感藥物和光的組合來治療各種醫學，包括一些癌症和非癌症疾病。它是一種微創方法，可以靶向並去除異常或惡性細胞，同時對周圍健康組織的傷害最小。動態療法 (PDT) 可用於治療多種疾病，包括癌症、老齡化黃斑部病變(AMD)、光化性角化症、痤瘡和其他皮膚病。

根據世界衛生組織 (WHO) 2022 年 2 月更新的關鍵事實，癌症是全球頭號死亡原因，2020 年將導致約 1,000 萬人死亡，約六分之一的死亡。他即將死於癌症。因此，全球患病盛行率不斷增加，對光敏劑的需求也預計會增加。

癌症和皮膚病的發生率增加

癌症發生率不斷上升，尤其是基底細胞癌和鱗狀細胞癌等皮膚惡性，推動了對 PDT 等有效替代療法的需求。隨著世界各地癌症發生率持續上升，PDT 能夠靶向癌細胞，同時最大限度地減少對健康組織的傷害，這是關鍵促進因素。此外，PDT 作為化療和標準手術的侵入性較小的治療方法替代方案而受到關注。隨著患者尋求侵入性較小的治療方法幫助他們更快康復並減少副作用，對 PDT 的需求不斷增加。

競爭治療方法與法規課題

在某些醫療情況下，PDT 經常與其他治療方法（例如手術、化療、放射線治療和免疫療法）競爭。這些其他治療方法的有效性或缺點可能會威脅 PDT 的市場佔有率。對於新的光敏藥物和 PDT 申請，法規核准過程可能漫長且困難。市場擴張可能會被推遲，獲得法規批准的延遲和課題可能會減少 PDT 的選擇範圍。由於缺乏保險覆蓋範圍以及使用 PDT 的環境受到限制，醫療保健專業人員和患者都對選擇 PDT 作為治療方案猶豫不決，這阻礙了市場的成長。但這種情況是有可能發生的。

將最新的影像影像方法與個體化治療方法相結合

個人化醫療和分子檢測的進步使得在設計 PDT 治療時可以考慮個別患者的特徵。此方法提高了治療效果和患者滿意度，並提供了一種將精準醫療涵蓋PDT治療的方法。透過改進影像技術，可以更好地觀察目標組織，從而提高 PDT 治療的準確性。螢光成像和分子成像是成像技術最新進展的兩個例子，它們可能為更有效的治療計劃和監測提供預測。

高可維護性

這種治療方法的主要問題之一是動態療法（PDT）的高成本。 PDT 的費用取決於多種要素，並且費用根據所治療的疾病、地點和醫療保健提供者而有所不同。 PDT 需要雷射或其他光源來活化光敏劑。這些設備的購買和維護費用昂貴。 PDT 中使用的光敏劑製造成本昂貴，並且可能無法廣泛使用，從而阻礙了市場成長。

COVID-19 的影響：

與其他醫療治療和手術一樣，動態療法 (PDT) 受到了 COVID-19 大大流行的顯著影響。然而，自那時以來，對 PDT 市場影響的規模和性質可能已經發生了變化。此次疫情的爆發對醫療保健產業造成了重大破壞。這些中斷影響了常用於治療非危及生命的疾病的 PDT，並可能導致治療延誤。全球供應鏈的中斷可能影響了醫療產品的製造和分銷，特別是用於 PDT 的光敏藥物。這可能導致獲得必要的 PDT 成分的延遲或短缺。

預計光敏劑領域在預測期內將是最大的

動態療法 (PDT) 是一種使用光活性物質來靶向並消除異常或惡性細胞的醫療程序，其關鍵組成部分有時被稱為光敏劑。這些藥物是 PDT 過程的重要組成部分，因為它們在暴露於特定波長的光時可以選擇性地殺死目標細胞。充當光敏劑的藥物對於 PDT 的有效性至關重要，因為它們可以進行標靶治療，同時對附近健康組織的傷害較小。成功的治療效果取決於合適光敏劑的選擇和治療參數的最佳化。

全身PDT領域預計在預測期內年複合成長率最高

在全身動態療法（PDT）中，光敏劑透過靜脈注射，使其在全身和目標細胞中循環。這種方法用於治療需要廣泛或深層嵌入異常細胞的疾病，例如某些癌症。全身 PDT 是治療傳統 PDT 難以治療的多種醫學疾病的一種有前途的方法。即使病變廣泛或根深蒂固，治療也是可能的，而該領域的持續研究正在擴大其用途並改善治療結果。確切的醫學問題和患者的具體情況將決定最佳的治療方案，無論是傳統的還是全身的 PDT。

比最大的地區

北美地區受美國重要公司的存在、癌症治療新生技藥品需求不斷成長、動態療法（PDT）採用率高以及市場參與者發布新產品的推動，預計將佔據最大市場佔有率。此外，美國食品藥物管理局(FDA)產品核可增加，動態動態病 (PDT) 的治療和管理激增，以及動態療法 (PDT) 的可用性增加。

複合年複合成長率最高的地區：

由於該地區癌症患者和其他可透過 PDT 治療的疾病數量不斷增加，預計亞太地區在預測期內的年複合成長率最高。 PDT 作為一種治療選擇越來越受歡迎，尤其是在日本、韓國、中國和印度等國家。隨著人口老化，老齡化相關性黃斑部病變（AMD）和某些皮膚惡性等與老齡化相關的疾病在亞太地區的一些高齡化變得越來越常見。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 用途分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球動態治療 (PDT) 市場：依產品

  • 光敏劑
    • 氨基乙醯丙酸
    • 氯
    • 卟啉衍生物
    • 血卟啉衍生物
    • 酞菁
    • 其他光敏劑
  • 動態治療儀
    • 二極體雷射
    • 免洗光纖光纖傳輸裝置
  • 其他產品

第6章 全球動態治療（PDT）市場：依適應症分類

  • 皮膚病
  • 眼科
  • 感染疾病
  • 癌症
  • 其他適應症

第7章 全球動態療法（PDT）市場：依治療類型

  • 局部PDT
  • 全身光動力療法
  • 表面光動力治療

第8章 全球動態治療（PDT）市場：依用途

  • 腫瘤學
  • 婦科
  • 消化內科
  • 泌尿系統
  • 皮膚科
  • 其他用途

第9章 全球動態治療 (PDT) 市場：依最終用戶分類

  • 醫院
  • 美容皮膚科診所
  • 門診手術中心
  • 研究機構
  • 其他最終用戶

第10章 全球動態治療（PDT）市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章公司簡介

  • Asieris Meditech Co., Ltd.
  • Bausch Health Companies Inc.
  • Biofrontera AG
  • Biolase, Inc
  • Biolitec AG
  • Boston Scientific Corporation
  • Candela Corporation
  • DUSA Pharmaceuticals
  • Galderma SA
  • Lumibird（Quantel Medical）
  • Modulight, Inc.
  • PDT Pharmaceuticals
  • Photocure ASA
  • Photothera
  • Quest PharmaTech Inc.
  • Soligenix
  • Sun Pharmaceutical Industries Limited
  • Theralase Technologies Inc.
Product Code: SMRC23833

According to Stratistics MRC, the Global Photodynamic Therapy Market is accounted for $5.60 billion in 2023 and is expected to reach $15.36 billion by 2030 growing at a CAGR of 15.5% during the forecast period. In order to treat a variety of medical illnesses, including some forms of cancer and other non-cancerous conditions, photodynamic therapy (PDT) employs a combination of photosensitive medications and light. With the least amount of harm to the surrounding healthy tissue, it is a minimally invasive method that can be used to target and eliminate aberrant or malignant cells. Photodynamic therapy can be used to treat various conditions, including cancer, age-related macular degeneration (AMD), actinic keratosis, acne and other skin conditions

According to World Health Organization (WHO), Key facts updated in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Thus, the increasing prevalence of cancer cases across the globe is expected to rise the demand for photosensitizer drugs

Market Dynamics:

Driver:

Rising rates of cancer and skin disorders

The demand for efficient treatment alternatives like PDT is driven by the increased incidence of cancer, particularly skin malignancies like basal cell carcinoma and squamous cell carcinoma. PDT's capacity to target cancer cells while limiting harm to healthy tissue becomes an important driver as cancer rates around the world continue to climb. In addition, PDT is viewed as a less invasive alternative to chemotherapy and standard surgery. The demand for PDT has grown as patients look for less invasive treatments with speedier recoveries and fewer side effects.

Restraint:

Competing therapeutic approaches and regulatory challenges

Depending on the medical situation, PDT frequently competes with other treatment techniques such surgery, chemotherapy, radiation therapy, and immunotherapy. The efficacy and drawbacks of these other treatments could threaten PDT's market share. For new photosensitive medications or PDT applications, regulatory approval procedures can be drawn-out and difficult. Market expansion might be slowed down and the range of PDT alternatives can be constrained by delays or challenges with obtaining regulatory licenses. Both healthcare professionals and patients may be discouraged from selecting PDT as a therapy option by inadequate insurance coverage or limitations on the circumstances under which PDT is covered which hampers the growth of the market.

Opportunity:

Modern imaging methods combined with personalized treatment methods

Individual patient characteristics may be taken into account while designing PDT treatments thanks to developments in personalized medicine and molecular testing. This method improves treatment results and patient satisfaction and offers a way to include precision medicine into PDT procedures. The accuracy of PDT treatments can be increased by improved imaging technologies that offer greater viewing of the targeted tissues. Fluorescence imaging and molecular imaging are two examples of recent advancements in imaging techniques that may offer prospects for more efficient intervention planning and monitoring thus creating wide range of opportunities for the growth of the market.

Threat:

High maintenance

One major issue with this treatment approach is the expensive expense of photodynamic therapy (PDT). PDT is expensive due to a number of factors, and these costs can change based on the illness being treated, the location, and the healthcare provider. Lasers or other types of light sources are needed for PDT in order to activate the photosensitizer. These gadgets can be expensive to buy and maintain. The photosensitive medications used in PDT can be costly to produce and may not be widely available thereby impedes the growth of the market.

COVID-19 Impact:

Photodynamic Therapy (PDT), like other medical treatments and procedures, was significantly impacted by the COVID-19 pandemic. But since then, it's possible that the size and character of the influence on the PDT market have changed. The epidemic caused significant disruptions in the healthcare industry. These interruptions may have had an impact on PDT, which is frequently used to treat non-life-threatening diseases, causing delays in therapy. Disruptions in global supply chains may have had an impact on the manufacture and distribution of medical products, especially photosensitive medications used in PDT. This might have caused delays or shortages in getting necessary PDT components.

The photosensitizer drugs segment is expected to be the largest during the forecast period

The photosensitizer drugs segment is estimated to have a lucrative growth, as these are a crucial element of Photodynamic Therapy (PDT), a medical procedure that employs light-activated substances to target and eliminate aberrant or malignant cells, are photosensitizer medications, sometimes referred to as simply photosensitizers. These medications are an essential component of the PDT procedure because they allow for the selective death of target cells when they are subjected to particular light wavelengths. Drugs that act as photosensitizers are essential to the efficacy of PDT because they allow for targeted treatment with little harm to nearby healthy tissue. Achieving successful therapeutic results depends on choosing the right photosensitizer and optimizing the therapy parameters.

The systemic PDT segment is expected to have the highest CAGR during the forecast period

The systemic PDT segment is anticipated to witness the highest CAGR growth during the forecast period, as photosensitizer medication is injected intravenously in systemic photodynamic therapy (PDT), which allows it to circulate throughout the body and target cells systemically. This method is used to treat diseases like some forms of cancer that require extensive or deeply embedded aberrant cells. A promising method of treating some medical diseases that are difficult to target with regular PDT is systemic PDT. Widespread or deeply positioned lesions can be treated, and continuous research in the field is expanding its uses and enhancing its results. The precise medical problem and the patient's unique circumstances will determine the best course of treatment, whether it is traditional PDT or systemic PDT.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the presence of significant companies in the United States, rising demand for new biologics for the treatment of cancer, a high rate of adoption of photodynamic therapy, and new product releases by market players. Moreover, as a result of an increase in product approvals by the US Food and Drug Administration, a surge in the use of photodynamic therapy for the treatment and management of actinic keratosis, and an increase in the number of cosmetologists offering photodynamic therapy.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to cancer cases and other illnesses that can be treated with PDT are on the rise in the Asia-Pacific region. PDT has been increasingly popular as a therapeutic option, particularly in nations like Japan, South Korea, China, and India. Age-related illnesses like age-related macular degeneration (AMD) and specific skin malignancies are more common due to the aging population in several Asia Pacific nations.

Key players in the market:

Some of the key players profiled in the Photodynamic Therapy Market include: Asieris Meditech Co., Ltd., Bausch Health Companies Inc., Biofrontera AG, Biolase, Inc, Biolitec AG, Boston Scientific Corporation, Candela Corporation , DUSA Pharmaceuticals, Galderma S.A., Lumibird (Quantel Medical), Modulight, Inc., PDT Pharmaceuticals, Photocure ASA, Photothera, Quest PharmaTech Inc., Soligenix, Sun Pharmaceutical Industries Limited and Theralase Technologies Inc.

Key Developments:

In May 2023, Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer. Asieris Pharmaceuticals will obtain exclusive global rights to UroViu's patented technology of portable single-use cystoscope in the field of fluorescent imaging.

In August 2022, Asieris Pharmaceuticals announced its multinational Phase III Clinical Trial of Cevira(APRICITY), novel non-surgical treatment of cervical high-grade squamous intraepithelial lesions (HSIL), has completed enrollment. Cevira is a breakthrough photodynamic drug-device combination product, based on the accumulation of a photosensitizer in the target cells.

Products Covered:

  • Photosensitizer Drugs
  • Photodynamic Therapy Devices
  • Other Products

Indications Covered:

  • Dermatological Conditions
  • Ophthalmology
  • Infectious Diseases
  • Cancer
  • Other Indications

Treatment Types Covered:

  • Local PDT
  • Systemic PDT
  • Topical PDT

Applications Covered:

  • Oncology
  • Gynecology
  • Gastroenterology
  • Urology
  • Dermatology
  • Other Applications

End Users Covered:

  • Hospitals
  • Cosmetic and Dermatology Clinics
  • Ambulatory Surgical Centers
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Photodynamic Therapy Market, By Product

  • 5.1 Introduction
  • 5.2 Photosensitizer Drugs
    • 5.2.1 Aminolevulinic Acid
    • 5.2.2 Chlorines
    • 5.2.3 Porphyrin Derivatives
    • 5.2.4 Hematoporphyrin Derivative
    • 5.2.5 Phthalocyanines
    • 5.2.6 Other Photosensitizer Drugs
  • 5.3 Photodynamic Therapy Devices
    • 5.3.1 Diode Lasers
    • 5.3.2 Disposable Fiber Optic Light Delivery Devices
  • 5.4 Other Products

6 Global Photodynamic Therapy Market, By Indication

  • 6.1 Introduction
  • 6.2 Dermatological Conditions
  • 6.3 Ophthalmology
  • 6.4 Infectious Diseases
  • 6.5 Cancer
  • 6.6 Other Indications

7 Global Photodynamic Therapy Market, By Treatment Type

  • 7.1 Introduction
  • 7.2 Local PDT
  • 7.3 Systemic PDT
  • 7.4 Topical PDT

8 Global Photodynamic Therapy Market, By Application

  • 8.1 Introduction
  • 8.2 Oncology
  • 8.3 Gynecology
  • 8.4 Gastroenterology
  • 8.5 Urology
  • 8.6 Dermatology
  • 8.7 Other Applications

9 Global Photodynamic Therapy Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Cosmetic and Dermatology Clinics
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Research Institutes
  • 9.6 Other End Users

10 Global Photodynamic Therapy Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Asieris Meditech Co., Ltd.
  • 12.2 Bausch Health Companies Inc.
  • 12.3 Biofrontera AG
  • 12.4 Biolase, Inc
  • 12.5 Biolitec AG
  • 12.6 Boston Scientific Corporation
  • 12.7 Candela Corporation
  • 12.8 DUSA Pharmaceuticals
  • 12.9 Galderma S.A.
  • 12.10 Lumibird (Quantel Medical)
  • 12.11 Modulight, Inc.
  • 12.12 PDT Pharmaceuticals
  • 12.13 Photocure ASA
  • 12.14 Photothera
  • 12.15 Quest PharmaTech Inc.
  • 12.16 Soligenix
  • 12.17 Sun Pharmaceutical Industries Limited
  • 12.18 Theralase Technologies Inc.

List of Tables

  • Table 1 Global Photodynamic Therapy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Photodynamic Therapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Photodynamic Therapy Market Outlook, By Photosensitizer Drugs (2021-2030) ($MN)
  • Table 4 Global Photodynamic Therapy Market Outlook, By Aminolevulinic Acid (2021-2030) ($MN)
  • Table 5 Global Photodynamic Therapy Market Outlook, By Chlorines (2021-2030) ($MN)
  • Table 6 Global Photodynamic Therapy Market Outlook, By Porphyrin Derivatives (2021-2030) ($MN)
  • Table 7 Global Photodynamic Therapy Market Outlook, By Hematoporphyrin Derivative (2021-2030) ($MN)
  • Table 8 Global Photodynamic Therapy Market Outlook, By Phthalocyanines (2021-2030) ($MN)
  • Table 9 Global Photodynamic Therapy Market Outlook, By Other Photosensitizer Drugs (2021-2030) ($MN)
  • Table 10 Global Photodynamic Therapy Market Outlook, By Photodynamic Therapy Devices (2021-2030) ($MN)
  • Table 11 Global Photodynamic Therapy Market Outlook, By Diode Lasers (2021-2030) ($MN)
  • Table 12 Global Photodynamic Therapy Market Outlook, By Disposable Fiber Optic Light Delivery Devices (2021-2030) ($MN)
  • Table 13 Global Photodynamic Therapy Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 14 Global Photodynamic Therapy Market Outlook, By Indication (2021-2030) ($MN)
  • Table 15 Global Photodynamic Therapy Market Outlook, By Dermatological Conditions (2021-2030) ($MN)
  • Table 16 Global Photodynamic Therapy Market Outlook, By Ophthalmology (2021-2030) ($MN)
  • Table 17 Global Photodynamic Therapy Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 18 Global Photodynamic Therapy Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 19 Global Photodynamic Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 20 Global Photodynamic Therapy Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 21 Global Photodynamic Therapy Market Outlook, By Local PDT (2021-2030) ($MN)
  • Table 22 Global Photodynamic Therapy Market Outlook, By Systemic PDT (2021-2030) ($MN)
  • Table 23 Global Photodynamic Therapy Market Outlook, By Topical PDT (2021-2030) ($MN)
  • Table 24 Global Photodynamic Therapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 25 Global Photodynamic Therapy Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 26 Global Photodynamic Therapy Market Outlook, By Gynecology (2021-2030) ($MN)
  • Table 27 Global Photodynamic Therapy Market Outlook, By Gastroenterology (2021-2030) ($MN)
  • Table 28 Global Photodynamic Therapy Market Outlook, By Urology (2021-2030) ($MN)
  • Table 29 Global Photodynamic Therapy Market Outlook, By Dermatology (2021-2030) ($MN)
  • Table 30 Global Photodynamic Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 31 Global Photodynamic Therapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 32 Global Photodynamic Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 33 Global Photodynamic Therapy Market Outlook, By Cosmetic and Dermatology Clinics (2021-2030) ($MN)
  • Table 34 Global Photodynamic Therapy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 35 Global Photodynamic Therapy Market Outlook, By Research Institutes (2021-2030) ($MN)
  • Table 36 Global Photodynamic Therapy Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.